Abstract
The effects of prognostic factors on local, regional or distant metastasis are standardly assessed separately. Competing risks analyses may be used to assess simultaneously the effects of factors on different types of first recurrence. Data for a cohort of 678 primary invasive breast cancer patients accrued between 1971 and 1990, updated to 1995, included type of first recurrence (local, regional, distant). We investigated the effects of the traditional factors of age, tumour size, nodal status, ER, PgR, adjuvant therapy (hormones, chemotherapy, radiotherapy) on type of recurrence and time to recurrence for all patients and for those aged ≥ 65. For all ages of patients, there were five factors with significant associations with type or time to first recurrence. Adjuvant radiation was the only factor which had an effect (P ≤ 0.05) on the type of first recurrence: being associated with a reduction in local recurrence. Age, nodal status, tumour size and adjuvant chemotherapy all had significant associations across all types of first recurrence, and in particular with time to recurrence for both local and distant metastasis. This indicates a potential lack of independence in these end-points. For patients ≥ 65 years of age, there were no factors which differentially affected type of recurrence, while only nodal status and tumour size had significant associations with time to recurrence. Analyses were used to assess simultaneously the effects of traditional prognostic factors and treatment options on type of first recurrence and time to first recurrence. The extension to evaluations with newer prognostic factors would expedite the determination and mode of biologic activity for such factors. © 1999 Cancer Research Campaign
Keywords: breast cancer, competing risks, prognostic factors
Full Text
The Full Text of this article is available as a PDF (110.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chapman J. W., Hanna W., Kahn H. J., Lickley H. L., Wall J., Fish E. B., McCready D. R. Alternative multivariate modelling for time to local recurrence for breast cancer patients receiving a lumpectomy alone. Surg Oncol. 1996 Oct-Dec;5(5-6):265–271. doi: 10.1016/s0960-7404(96)80031-4. [DOI] [PubMed] [Google Scholar]
- Fish E. B., Chapman J. A., Link M. A. Competing causes of death for primary breast cancer. Ann Surg Oncol. 1998 Jun;5(4):368–375. doi: 10.1007/BF02303502. [DOI] [PubMed] [Google Scholar]
- Gamel J. W., Meyer J. S., Province M. A. Proliferative rate by S-phase measurement may affect cure of breast carcinoma. Cancer. 1995 Sep 15;76(6):1009–1018. doi: 10.1002/1097-0142(19950915)76:6<1009::aid-cncr2820760615>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
- Gamel J. W., Vogel R. L., Valagussa P., Bonadonna G. Parametric survival analysis of adjuvant therapy for stage II breast cancer. Cancer. 1994 Nov 1;74(9):2483–2490. doi: 10.1002/1097-0142(19941101)74:9<2483::aid-cncr2820740915>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
- Gelman R., Gelber R., Henderson I. C., Coleman C. N., Harris J. R. Improved methodology for analyzing local and distant recurrence. J Clin Oncol. 1990 Mar;8(3):548–555. doi: 10.1200/JCO.1990.8.3.548. [DOI] [PubMed] [Google Scholar]
- Prentice R. L., Marek P. A qualitative discrepancy between censored data rank tests. Biometrics. 1979 Dec;35(4):861–867. [PubMed] [Google Scholar]
- Rutqvist L. E., Wallgren A., Nilsson B. Is breast cancer a curable disease? A study of 14,731 women with breast cancer from the Cancer Registry of Norway. Cancer. 1984 Apr 15;53(8):1793–1800. doi: 10.1002/1097-0142(19840415)53:8<1793::aid-cncr2820530832>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
- Veronesi U., Marubini E., Del Vecchio M., Manzari A., Andreola S., Greco M., Luini A., Merson M., Saccozzi R., Rilke F. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst. 1995 Jan 4;87(1):19–27. doi: 10.1093/jnci/87.1.19. [DOI] [PubMed] [Google Scholar]